-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Alkermes, Maintains $62 Price Target

Benzinga·09/21/2026 14:03:04
Needham analyst Ami Fadia reiterates Alkermes (NASDAQ:ALKS) with a Buy and maintains $62 price target.